Advanced & Targeted Drug Delivery Market Landscape Limelighted in New Kelly Scientific Publications Study Available at

11 Apr 2016 • by Natalie Aster

LONDON – The advanced and targeted drug delivery marketplace is projected to grow at a 10.4% CAGR to reach USD 319 billion by end-2021 from the current value of USD 168 billion.

What are the maximum drug release times reported for different nanotechnology-based drug carriers? What regulatory bodies are approving particular nanomedicines? How many liposome-based drug products are currently in the market? How many stealth liposomes regulatory authorities have granted approval to? How many PEGylated liposomes are utilised for targeted drug delivery? Who are the most prominent players in the liposome drug formulation field? What are smart polymers? Who takes the lead in the polymer-based drug market? What commercially available dendrimer-based drugs are used for targeted delivery? What are drug delivery applications for inorganic nanomaterials? Which firms are focused on inorganic nanoparticles for targeted drug delivery purposes? What are the applications for the use of magnetic nanoparticles in drug delivery, diagnostic and imaging? What is the value of the global nanomedicines market? What is the worldwide market for nanomedicines by areas of medicine? What is the global market for monoclonal antibodies based on geographical area? What are the best-selling mAbs? What is the global market for major targeted delivery systems? These and many more questions are addressed in the research report.

New research report “Advanced and Targeted Drug Delivery Market” created by Kelly Scientific Publications offers an in-depth analysis on the advanced and targeted drug delivery market on a global scale. The market for advanced and targeted drug delivery is segmented and assessed to 2021 with a corresponding breakdown of CAGR by technology, therapeutic area, geography, and a detailed analysis of the various sub markets. The study identifies all-new R&D papers and patents and delves deep into disruptive technology platforms, which is revolutionising drug delivery systems. It presents a stakeholder analysis of the leading players including developers, innovators, and commercial partners.  The report gives an overview of 170 companies involved. The research publication contains details of how is the uptake of cutting-edge technologies is changing the drug delivery universe as well as how emerging products such as PEGylated phospholipid nanocarriers, hydrogels and cyclodextrins are disrupting traditional marketplaces.

Report Details:

Advanced and Targeted Drug Delivery Market Segmentation, Analysis & Forecast to 2021Nanoparticles, Polymers, Liposomes, Micelles, Nanoemulsions, Dendrimers, Monoclonal Antibodies by Geography, Therapeutic Area and Stakeholder Environment
Published: April, 2016
Pages: 382
Price: US$ 3,800.00

Research studies by the publisher can be found at Kelly Scientific Publications page.


The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970